BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » strategic partnership

Commercial Momentum Accelerates as Cynata Enters License Option Agreement with apceth GmbH & Co. KG

May 11, 2016 By Cade Hildreth (CEO) Leave a Comment

Commercial Momentum Accelerates as Cynata Enters License Option Agreement with apceth GmbH & Co. KG

In major news released today, Cynata announced that it has entered into a License Option agreement with apceth GmbH & Co. KG.  The agreement provides apceth with an option to certain uses of Cynata’s unique Cymerus™ mesenchymal stem cell (MSC) technology, exercisable by apceth into a definitive license agreement.

The relationship combines Cynata’s Cymerus MSC technology with apceth’s technologies for genetically modifying MSCs  to open up prospective new therapeutic fields, particularly the treatment of cancer.  This substantially broadens the commercial horizons for Cymerus, as it provides both an immediate cash payment as well as the potential to provide substantial license revenue in the form of milestones and royalties on eventual product sales.  Cynata will work with apceth in the coming months to plan out the development path for the scope of the agreement and also explore other areas into which the relationship could be extended. [Read more…]

Filed Under: iPS Cells, MSCs Tagged With: apceth GmbH, cynata, strategic partnership

CarePilot and “Cord for Life” Find Innovative Way to Make Cord Blood Banking Affordable

September 8, 2015 By Cade Hildreth (CEO) Leave a Comment

CarePilot and Lifeforce Cryobanks Announce Partnership to Make Cord Blood Banking Affordable

In August 2014, CarePilot USA, based in Newport Beach, California, announced a collaboration with the “Cord for Life” storage program offered by Lifeforce Cryobanks, a company based in Altamonte Springs, Florida.  Through this partnership, CarePilot is now offering significant discounts on the collection, processing, and storage of newborn umbilical cord blood.  Specifically, CarePilot is offering two, six, and 21-year storage plans at major discounts relative to the market rates offered by the “Cord for Life” program. [Read more…]

Filed Under: Cord Blood, HSCs, MSCs Tagged With: alliances, carepilot, cord blood banking, lifeforce cryobanks, market news, strategic partnership

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.